Detalles de la búsqueda
1.
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Ann Rheum Dis
; 79(11): 1400-1413, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32759265
2.
Evaluating the Effectiveness of New York City Health Policy Initiatives in Reducing Cardiovascular Disease Mortality, 1990-2011.
Am J Epidemiol
; 186(5): 555-563, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28911010
3.
Implications for Improving Fetal Death Vital Statistics: Connecting Reporters' Self-Identified Practices and Barriers to Third Trimester Fetal Death Data Quality in New York City.
Matern Child Health J
; 20(2): 337-46, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26518007
4.
Evaluating the Use of an Electronic Death Registration System for Mortality Surveillance During and After Hurricane Sandy: New York City, 2012.
Am J Public Health
; 105(11): e55-62, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26378834
5.
How well do birth records serve maternal and child health programs? Birth registration system evaluation, New York City, 2008-2011.
Matern Child Health J
; 19(7): 1559-66, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25604629
6.
Reliability of Reported Maternal Smoking: Comparing the Birth Certificate to Maternal Worksheets and Prenatal and Hospital Medical Records, New York City and Vermont, 2009.
Matern Child Health J
; 19(9): 1916-24, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25676044
7.
Effect of cause-of-death training on agreement between hospital discharge diagnoses and cause of death reported, inpatient hospital deaths, New York City, 2008-2010.
Prev Chronic Dis
; 12: E04, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25590598
8.
Understanding perinatal death: a systematic analysis of New York City fetal and neonatal death vital record data and implications for improvement, 2007-2011.
Matern Child Health J
; 18(8): 1945-54, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24522520
9.
Test of an electronic program to query clinicians about nonspecific causes reported for pneumonia deaths, New York City, 2012.
Prev Chronic Dis
; 11: E210, 2014 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25427318
10.
Evaluating New York City's abortion reporting system: insights for public health data collection systems.
J Public Health Manag Pract
; 20(4): 392-400, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24281129
11.
A case study of the impact of inaccurate cause-of-death reporting on health disparity tracking: New York City premature cardiovascular mortality.
Am J Public Health
; 103(4): 733-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22994186
12.
Programmatic impact of 5 years of mortality surveillance of New York City homeless populations.
Am J Public Health
; 103 Suppl 2: S193-8, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24148068
13.
Impact of a hospital-level intervention to reduce heart disease overreporting on leading causes of death.
Prev Chronic Dis
; 10: E77, 2013 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23680506
14.
Causal models for investigating complex disease: I. A primer.
Hum Hered
; 72(1): 54-62, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21912138
15.
Causal models for investigating complex genetic disease: II. what causal models can tell us about penetrance for additive, heterogeneity, and multiplicative two-locus models.
Hum Hered
; 72(1): 63-72, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21912139
16.
An intervention to improve cause-of-death reporting in New York City hospitals, 2009-2010.
Prev Chronic Dis
; 9: E157, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23078668
17.
Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.
Clin Pharmacol Ther
; 111(1): 77-89, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839524
18.
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study.
J Rheumatol
; 49(3): 320-329, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34782447
19.
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure.
RMD Open
; 7(2)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34045358
20.
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry.
ACR Open Rheumatol
; 3(3): 173-184, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570260